| Title |
Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
|
|---|---|
| Published in |
BMC Neurology, February 2019
|
| DOI | 10.1186/s12883-019-1252-3 |
| Pubmed ID | |
| Authors |
C. R. A. Silveira, J. MacKinley, K. Coleman, Z. Li, E. Finger, R. Bartha, S. A. Morrow, J. Wells, M. Borrie, R. G. Tirona, C. A. Rupar, G. Zou, R. A. Hegele, D. Mahuran, P. MacDonald, M. E. Jenkins, M. Jog, S. H. Pasternak |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 20% |
| United Kingdom | 2 | 13% |
| Japan | 1 | 7% |
| Korea, Republic of | 1 | 7% |
| Unknown | 8 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 87% |
| Scientists | 1 | 7% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 234 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 234 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 31 | 13% |
| Researcher | 30 | 13% |
| Student > Bachelor | 26 | 11% |
| Student > Ph. D. Student | 19 | 8% |
| Student > Doctoral Student | 10 | 4% |
| Other | 41 | 18% |
| Unknown | 77 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 16% |
| Neuroscience | 29 | 12% |
| Biochemistry, Genetics and Molecular Biology | 15 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 6% |
| Nursing and Health Professions | 12 | 5% |
| Other | 34 | 15% |
| Unknown | 94 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2023.
All research outputs
#2,186,244
of 25,789,020 outputs
Outputs from BMC Neurology
#197
of 2,729 outputs
Outputs of similar age
#51,364
of 455,187 outputs
Outputs of similar age from BMC Neurology
#6
of 25 outputs
Altmetric has tracked 25,789,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,729 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,187 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.